Study at a glance
What was studied?
This review compares human B-cell experiments, lupus immune-cell measurements and vaccine studies. B cells produce antibodies, proteins that recognise particular targets, and can contribute to responses when a target appears again. The studies tested active hormone, vitamin D3 or calcifediol, a circulating form requiring activation.
What was found?
Active hormone could increase antibody-secreting cells under one laboratory protocol. Some blood memory B-cell measurements fell in a small study of lupus, an autoimmune disease involving reactions against the body’s own material, without an untreated comparison. The elderly influenza trial and larger CORONAVIT vaccine analysis did not establish an overall benefit. Smaller positive vaccine reports had important problems with group assignment, follow-up or reporting.
What does it mean?
Changes in cell proteins, antibody signals or memory-associated genes are not the same as lasting protection against infection. Lower memory-cell measurements during autoimmune disease do not prove stronger protective memory.
What are the limits?
The studies measured different outcomes. A later study of genes used people from the earlier study, so it was not independent confirmation. Long-lived protective memory remains uncertain. The forms and amounts tested do not establish a personal supplement regimen.
Read the full article below ↓Vitamin D can change B-cell activity, but the reviewed studies do not establish stronger lasting immune memory. Laboratory experiments, lupus immune-cell measurements and vaccine trials tested different outcomes. Larger randomized vaccine evidence did not show a consistent benefit. Some smaller reports were positive but had important limitations. The detailed counterpart is Vitamin D, B-Cell Function and the Limits of Immune Memory Evidence: Full Evidence Review.
What was studied?
B cells produce antibodies, which recognise particular targets. Some B cells help respond when a target appears again. T cells also contribute to memory. An antibody change today does not by itself show protection months or years later. This distinction is central to Vitamin D and Immune Memory.
The review compared human B-cell experiments, a small lupus intervention, an elderly influenza-vaccine trial and the CORONAVIT vaccine studies. Smaller positive COVID-19 vaccine reports were also assessed. Four central studies do not mean four direct trials of long-lived memory formation.
What happened in B-cell experiments?
Treptow grew human naive B cells, which have not yet responded to their particular target. Under specific activating signals, calcitriol, the active vitamin D hormone, could increase antibody-secreting cells and immunoglobulin A, a type of antibody. A vitamin-A-related compound was also tested, so combined effects cannot all be assigned to vitamin D. [1]
The experiment lasted about seven days. It did not show lasting protection, fewer infections or long-lived antibody-producing cells in people. Direct active-hormone exposure differs from taking vitamin D3 by mouth.
Lupus is an autoimmune disease, in which immunity reacts against the body’s own material. In twenty women with relatively inactive lupus, some blood memory B-cell measurements fell during supplementation. There was no untreated comparison group. The measurements did not identify every memory cell as directed against the body. They did not show better protective memory against infection, and disease activity did not clearly improve. [2]
Vitamin D and Immune Tolerance explains why restraining inappropriate responses differs from increasing protective memory.
What did the stronger vaccine comparisons find?
The influenza trial analysed thirty-eight older adults, nineteen per group. Assignment was by chance. One group received placebo, a comparison without vitamin D. Vitamin D status increased, but overall vaccine antibody responses did not improve. Some results for particular influenza-virus types favoured placebo. There were too few participants to reliably detect some effects, and responses were assessed only twenty-eight days after vaccination. The trial did not prove universal harm or no possible benefit. [3]
CORONAVIT did not establish fewer infections after vaccination or clear improvements in tested antibody and cellular responses. Different groups supplied different measurements within one parent trial. They were not independent trials. Controls had no measured vitamin D concentration at the start. Analyses excluded people who reported taking assigned capsules less than half the time and controls who reported any vitamin D supplement use. These exclusions limit how fully chance assignment protects the comparison. Follow-up did not establish years of protection. [4]
Why do positive reports need caution?
Bhat’s programme tested calcifediol, the circulating precursor that cells can convert to active hormone. It reported more cell division after cells encountered virus-related material in a laboratory test, and fewer probable COVID-19 illnesses. Participants chose treatment or placebo, so other group differences could affect results. Follow-up was incomplete, and probable illness was not always confirmed by an infection test. [5]
A later twenty-four-person gene study used people from that programme. It was not independent confirmation. Changes in memory-associated genes did not prove functional long-lived memory or fewer infections. [8]
Cesur’s small study reported a higher antibody signal at four weeks, but no significant difference between groups at eight weeks. Assignment was not clearly explained, groups differed at the start and dose descriptions disagreed. Fateh’s positive report had differing participant totals, important group differences and an antibody test that was not clearly described. Neither demonstrated lasting memory or clinical protection. [6] [7]
What does this mean?
Vitamin D and Immune Modulation explains response regulation; this does not mean increasing every response. Older-adult vaccine findings relate to Vitamin D and Immune Ageing but do not show reversal of age-related immune change.
Vitamin D can affect some B-cell functions, while lasting protective benefit remains uncertain. The forms and amounts tested differ and do not establish a personal regimen for improving vaccine memory.
Primary sources
[1] Treptow S et al. 9-cis Retinoic acid and 1.25-dihydroxyvitamin D3 drive differentiation into IgA+ secreting plasmablasts in human naïve B cells. European journal of immunology. 2021;51(1):125-137. DOI: 10.1002/eji.202048557. PMID: 33107588.
[2] Terrier B et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis research & therapy. 2012;14(5):R221. DOI: 10.1186/ar4060. PMID: 23075451.
[3] Goncalves-Mendes N et al. Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. Frontiers in immunology. 2019;10:65. DOI: 10.3389/fimmu.2019.00065. PMID: 30800121.
[4] Jolliffe DA et al. Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial. Nutrients. 2022;14(18):3821. DOI: 10.3390/nu14183821. PMID: 36145196.
[5] Bhat S et al. Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial. The Journal of infection. 2023;86(5):e120-e122. DOI: 10.1016/j.jinf.2023.03.004. PMID: 36889512.
[6] Cesur F et al. Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial. Vaccine. 2023;41(17):2860-2867. DOI: 10.1016/j.vaccine.2023.03.046. PMID: 37003908.
[7] Fateh HL et al. The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial. Clinical nutrition research. 2023;12(4):269-282. DOI: 10.7762/cnr.2023.12.4.269. PMID: 37969936.
[8] Saroha HS et al. Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses. NPJ vaccines. 2024;9(1):114. DOI: 10.1038/s41541-024-00909-w. PMID: 38902265.
Related reading
Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses
In our previous study eligible subjects were supplemented with calcifediol, a direct precursor to the biologically active form of vitamin D, calcitriol with an objective to enhance the immunogenicity of the COVISHIELD vaccine.
Original paper ↗Read more →Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial
This randomized placebo-controlled double-blind trial investigated whether Vit-D supplementation in deficient elderly persons could improve influenza seroprotection and immune response.
Original paper ↗Read more →Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation
In this prospective study, we evaluated the safety and the immunological effects of vitamin D supplementation (100 000 IU of cholecalciferol per week for 4 weeks, followed by 100 000 IU of cholecalciferol per month for 6 months.) in 20 SLE patients with hypovitaminosis D.
Original paper ↗Read more →Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial
Sub-study 1 (n = 2808) investigated the effects of vitamin D supplementation on the risk of breakthrough SARS-CoV-2 infection following two doses of SARS-CoV-2 vaccine.
Original paper ↗Read more →Vitamin D, B-Cell Function and the Limits of Immune Memory Evidence: Full Evidence Review
A review of B-cell experiments and vaccine trials, separating memory-cell markers and antibody changes from lasting protection against infection.
Read more →Correlation between Baseline 25(OH) Vitamin D Levels and Both Humoral Immunity and Breakthrough Infection Post-COVID-19 Vaccination
Objective: Vaccines against COVID-19 induce specific antibodies whose titer is perceived as a reliable correlate of protection.
Original paper ↗Read more →Dysregulated lipid metabolism networks modulate T-cell function in people with relapsing-remitting multiple sclerosis
RNA-sequencing and pathway analysis identified that genes within the ‘lipid metabolism’ and ‘signalling of nuclear receptors’ pathways were dysregulated in CD4 + T cells isolated from RRMS patients compared with healthy donors.
Original paper ↗Read more →The Vitamin D Receptor and T Cell Function
The vitamin D receptor (VDR) is a nuclear, ligand-dependent transcription factor that in complex with hormonally active vitamin D, 1,25(OH)2D3, regulates the expression of more than 900 genes involved in a wide array of physiological functions.
Original paper ↗Read more →Vitamin D and Immune Memory
Explains how vitamin D relates to immune memory, T and B cells, cytokine signalling, antigen presentation, immune ageing, and long-term immune readiness.
Read more →Vitamin D, Immune Memory Formation and Recall Across Age: Full Evidence Review
How vitamin D studies distinguish vaccine responses, memory cells, recall and ageing, and why short-term findings do not establish lasting protection.
Read more →Vitamin D, Immune Memory Formation and Recall Across Age: Study Summary
A plain-English guide to vitamin D, vaccination, immune recall and ageing.
Read more →Association between Vitamin D Serum Levels and Immune Response to the BNT162b2 Vaccine for SARS-CoV-2
The use of micronutrients such as vitamin D could improve the response to viral vaccines, particularly in immunosuppressed and immunosenescent subjects.
Original paper ↗Read more →Immune Response after Anti-SARS-CoV-2 mRNA Vaccination in Relation to Cellular Immunity, Vitamin D and Comorbidities in Hemodialysis Patients
Existing data indicate that they tend to exhibit a reduced immune response to vaccines compared to the general population.
Original paper ↗Read more →One-Year Consumption of a Mediterranean-Like Dietary Pattern With Vitamin D3 Supplements Induced Small Scale but Extensive Changes of Immune Cell Phenotype, Co-receptor Expression and Innate Immune Responses in Healthy Elderly Subjects: Results From the United Kingdom Arm of the NU-AGE Trial
Amongst the major features of aging are chronic low grade inflammation and a decline in immune function.
Original paper ↗Read more →Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
In several autoimmune diseases, including multiple sclerosis (MS), a compromised regulatory T cell (Treg) function is believed to be critically involved in the disease process.
Original paper ↗Read more →Serum 25-Hydroxyvitamin D Level and Influenza Vaccine Immunogenicity in Children and Adolescents
The purpose of this study was to determine if serum 25(OH)D level correlates with influenza vaccine immunogenicity in children and adolescents.
Original paper ↗Read more →The Expressions of the Immunity: and Muscle Development-Related Genes of 40-Day-Old Broilers Are Promoted in Response to the In Ovo and Dietary Supplemental Administration of Calcidiol in Conjunction with the In Ovo Administration of Marek’s Disease Vaccine †
The purpose of the current study was to identify the impacts of supplemental 25(OH)D3 administered dietarily or by in ovo injection in conjunction with the in ovo delivery of Marek’s Disease vaccine (MVD), on the expression of genes in the spleen and pectoralis major (P.
Original paper ↗Read more →Association between circulating ascorbic acid, α-tocopherol, 25-hydroxyvitamin D, and plasma cytokine concentrations in young adults: a cross-sectional study
Our objective was to examine the association between circulating concentrations of ascorbic acid, α-tocopherol, and 25(OH) D and a panel of pro-inflammatory cytokines in an ethnically diverse population of young adults.
Original paper ↗Read more →Dendritic cells, engineered to overexpress 25-hydroxyvitamin D 1α-hydroxylase and pulsed with a myelin antigen, provide myelin-specific suppression of ongoing experimental allergic encephalomyelitis
Current therapies aim to block such immune responses.
Original paper ↗Read more →Gut microbiota interactions with the immunomodulatory role of 25-hydroxyvitamin D in children with infectious mononucleosis
A total of 99 participants were divided into three groups, based on the level of 25(OH)D.
Original paper ↗Read more →Seasonal 25-hydroxyvitamin D levels in new childhood-onset SLE: associations with disease activity and peripheral lymphocyte subsets
All participants were divided into a winter-spring group and a summer-autumn group according to sampling seasons.
Original paper ↗Read more →Original sources
9-cis Retinoic acid and 1.25-dihydroxyvitamin D3 drive differentiation into IgA+ secreting plasmablasts in human naïve B cells
Published in European journal of immunology (2021).
Publication details
[1] Treptow S et al. 9-cis Retinoic acid and 1.25-dihydroxyvitamin D3 drive differentiation into IgA+ secreting plasmablasts in human naïve B cells. European journal of immunology. 2021;51(1):125-137. DOI: 10.1002/eji.202048557. PMID: 33107588.
Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation
In this prospective study, we evaluated the safety and the immunological effects of vitamin D supplementation (100 000 IU of cholecalciferol per week for 4 weeks, followed by 100 000 IU of cholecalciferol per month for 6 months.) in 20 SLE patients with hypovitaminosis D.
Publication details
[2] Terrier B et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis research & therapy. 2012;14(5):R221. DOI: 10.1186/ar4060. PMID: 23075451.
Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial
This randomized placebo-controlled double-blind trial investigated whether Vit-D supplementation in deficient elderly persons could improve influenza seroprotection and immune response.
Publication details
[3] Goncalves-Mendes N et al. Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. Frontiers in immunology. 2019;10:65. DOI: 10.3389/fimmu.2019.00065. PMID: 30800121.
Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial
Sub-study 1 (n = 2808) investigated the effects of vitamin D supplementation on the risk of breakthrough SARS-CoV-2 infection following two doses of SARS-CoV-2 vaccine.
Publication details
[4] Jolliffe DA et al. Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial. Nutrients. 2022;14(18):3821. DOI: 10.3390/nu14183821. PMID: 36145196.
Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial
Published in The Journal of infection (2023).
Publication details
[5] Bhat S et al. Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial. The Journal of infection. 2023;86(5):e120-e122. DOI: 10.1016/j.jinf.2023.03.004. PMID: 36889512.
Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial
Published in Vaccine (2023).
Publication details
[6] Cesur F et al. Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial. Vaccine. 2023;41(17):2860-2867. DOI: 10.1016/j.vaccine.2023.03.046. PMID: 37003908.
The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial
Published in Clinical nutrition research (2023).
Publication details
[7] Fateh HL et al. The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial. Clinical nutrition research. 2023;12(4):269-282. DOI: 10.7762/cnr.2023.12.4.269. PMID: 37969936.
Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses
In our previous study eligible subjects were supplemented with calcifediol, a direct precursor to the biologically active form of vitamin D, calcitriol with an objective to enhance the immunogenicity of the COVISHIELD vaccine.
Publication details
[8] Saroha HS et al. Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses. NPJ vaccines. 2024;9(1):114. DOI: 10.1038/s41541-024-00909-w. PMID: 38902265.